Transportation and logistics is becoming a progressively more important part of the healthcare industry as it bends backward to ensure that drugs reach consumer at the right place at the right time and most importantly, with uncompromised safety. The development of biologics will further boost spends on healthcare cold chain logistics, says Transparency Market Research in its report, titled, ‘Healthcare Cold Chain Logistics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.’
According to the report, there is a conspicuous rise in the demand for cold chain logistics in the healthcare industry thanks to substances such as blood plasma, tissues, pharmaceutical products, and sensitive chemicals being transported both domestically and internationally. A variety of other drugs – such as birth control pills, dermatological therapies, and anti-depressants – are sensitive to heat, moisture and moisture. This, too, necessitates the reliance on healthcare cold chain logistics.
Some of the most common mediums of transportation used in the healthcare cold chain logistics market are: reefer ships, containers, reefer cars, and refrigerated trucks. The need for dependable healthcare cold chain logistics is even greater in underserved regions with harsh or variable climatic conditions where patients usually suffer because of the lack of a proper logistical network. Thus, companies in the healthcare cold chain logistics market will find growth opportunities in developing and underdeveloped regions.
For a highly detailed study, the report segments the global healthcare cold chain logistics market on the basis of products, logistics techniques, and geography. By product type, the market is segmented into vaccines, biopharmaceuticals, and clinical trial materials. On the basis of techniques, the market is composed of liquid nitrogen, dry ice, and gel packs. These segments are studied for the period ranging from 2013 to 2019.
The mammoth size of the healthcare industry, which has been lately been shaped by the advent of biological drugs, in itself presents a massive playing field for companies in the healthcare cold chain logistics market. The WHO pegs the worth of the global pharmaceutical industry at US$300 bn as of 2015. Bulging pharmaceutical trade volumes will help this industry stand at approximately US$ 400 bn before 2020. Companies such as India are now exporting more drugs every year to feed the rising demand for medicines – a trend that augurs well for the global healthcare cold chain logistics industry.
Companies that are studied in the Company Profiles section of the report include:
DHL International GmbH, Kuehne and Nagel International AG, FedEx Corporation, Continental Air Cargo, LifeConEx, LLC, DB Schenker, Inc., United Parcel Service Inc., and World Courier.
The global healthcare cold chain logistics market is categorized based on the following:
- Clinical trial materials
- Dry ice
- Liquid nitrogen
- Gel packs
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.